Furthermore, IHC analysis revealed a progressive increase in IDO1 expression and the numbers of Tregs in the third generation of tumors (S3), which is indicative of tumor immune evasion and the potentially suboptimal efficacy of STING agonists (Supplemental Figure 6D). The gene discussed is IDO1; the disease is neoplasm.